As of Aug 17
| +0.0101 / +1.71%|
The 1 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +733.19% increase from the last price of 0.60.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.